| Date | Time | Source | Headline | Symbol | Company |
| 05/19/2009 | 9:08AM | Business Wire | Impax Receives FDA Approval for Generic Precose® Tablets, 25 mg, 50 mg and 100 mg | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/11/2009 | 5:00PM | Business Wire | Impax Laboratories Added to NASDAQ Biotechnology Index | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/07/2009 | 5:10PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/07/2009 | 5:09PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/07/2009 | 1:17PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/06/2009 | 5:46PM | Business Wire | Impax Receives Final FDA Approval for Generic Depakote® Extended-Release 250mg Tablets | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/06/2009 | 2:11PM | Business Wire | Impax to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference May 13 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/05/2009 | 4:02PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/05/2009 | 10:06AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/05/2009 | 8:00AM | Business Wire | Impax Reports Improved First Quarter 2009 Revenue and Profit | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/28/2009 | 12:36PM | Business Wire | Impax to Host First Quarter 2009 Earnings Conference Call and Webcast on May 5 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/22/2009 | 12:21PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/20/2009 | 2:47PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/20/2009 | 8:47AM | Business Wire | Impax Pharmaceuticals Reports Positive Achievements on its Two Leading Brand Product Candidates IPX066 and IPX056 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/14/2009 | 3:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/14/2009 | 3:06PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/09/2009 | 6:00AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/08/2009 | 4:23PM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/06/2009 | 12:44PM | Business Wire | Impax Confirms Patent Challenge Relating to Renvela® 800 mg Tablets | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/27/2009 | 4:57PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/25/2009 | 5:39PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/20/2009 | 3:33PM | Business Wire | Impax Confirms Patent Lawsuit Relating to Doryx® Tablets 150 mg | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/19/2009 | 8:38AM | Business Wire | Impax Pharmaceuticals to Co-Promote Wyeth’s Pristiq® | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/17/2009 | 3:37PM | Business Wire | Impax Confirms ANDA Filing for Doryx® Tablets 150 mg | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/17/2009 | 8:40AM | Business Wire | Impax Confirms Patent Challenge Relating to RENAGEL® Tablets, 400 mg and 800 mg | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/16/2009 | 1:51PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/05/2008 | 4:05PM | Marketwired | I-many Reports Record Fourth Quarter and Fiscal 2007 Financial Results | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/05/2006 | 10:55AM | Business Wire | IMPAX Receives FDA Approval for Generic Version of SALAGEN(R) Tablets; Global Pharmaceuticals Division to Launch | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/18/2006 | 3:17PM | PR Newswire (US) | ADDERALL XR(R) - Litigation Update | NASDAQ:IPXL | |
| 11/18/2004 | 7:15PM | PR Newswire (US) | Shareholder Class Action Filed Against IMPAX Laboratories, Inc. by the Law Firm of Schiffrin & Barroway, LLP | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |